Authors:
ROMAGUERA JE
DIAZPAVON JR
CARIAS L
HAGEMEISTER FB
MCLAUGHLIN P
RODRIGUEZ MA
SARRIS AH
YOUNES A
PRETI A
BACHIER C
LLERENA E
CABANILLAS F
Citation: Je. Romaguera et al., USE OF THE INTERNATIONAL PROGNOSTIC INDEX AND THE TUMOR SCORE TO DETECT POOR-RISK PATIENTS WITH PRIMARY MEDIASTINAL LARGE B-CELL LYMPHOMA -A STUDY OF 37 PREVIOUSLY UNTREATED PATIENTS, Leukemia & lymphoma, 28(3-4), 1998, pp. 295-306
Authors:
POPAT U
PRZEPIORK D
CHAMPLIN R
PUGH W
AMIN K
MEHRA R
RODRIGUEZ J
GIRALT S
ROMAGUERA J
RODRIGUEZ A
PRETI A
ANDERSSON B
KHOURI I
CLAXTON D
DELIMA M
DONATO M
ANDERLINI P
GAJEWSKI J
CABANILLAS F
VANBESIEN K
Citation: U. Popat et al., HIGH-DOSE CHEMOTHERAPY FOR RELAPSED AND REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA - MEDIASTINAL LOCALIZATION PREDICTS FOR A FAVORABLE OUTCOME, Journal of clinical oncology, 16(1), 1998, pp. 63-69
Authors:
MONTI E
DEMASI L
PICCINOTTI A
BRESCIANI R
BIANCARDI L
PRETI A
MARCHESINI S
Citation: E. Monti et al., PHYSICOCHEMICAL PROPERTIES AND METABOLISM OF LISSAMINE-RHODAMINE CERAMIDES - EFFECT OF ACYL-CHAIN LENGTH, Chemistry and physics of lipids, 92(2), 1998, pp. 105-115
Authors:
YOUNES A
RODRIGUEZ MA
MCLAUGHLIN P
NORTH L
SARRIS AH
PATE O
HAGEMEISTER FB
ROMAGUERA J
PRETI A
BACHIER C
CABANILLAS F
Citation: A. Younes et al., PHASE-I STUDY OF FLUDARABINE AND PACLITAXEL FOR THE TREATMENT OF LOW-GRADE NON-HODGKINS-LYMPHOMA, Leukemia & lymphoma, 26(1-2), 1997, pp. 77-82
Authors:
YOUNES A
AYOUB JP
SARRIS A
HAGEMEISTER F
NORTH L
PATE O
MCLAUGHLIN P
RODRIGUEZ MA
ROMAGUERA J
KURZROCK R
PRETI A
BACHIER C
SMITH T
CABANILLAS F
Citation: A. Younes et al., PACLITAXEL ACTIVITY FOR THE TREATMENT OF NON-HODGKINS-LYMPHOMA - FINAL REPORT OF A PHASE-II TRIAL, British Journal of Haematology, 96(2), 1997, pp. 328-332
Authors:
SARRIS AH
SANTIAGO M
PRETI A
MESINA O
HAGEMEISTER F
MCLAUGHLIN P
RODRIGUEZ MA
ROMAGUERA J
YOUNES A
RIGGS S
HA C
MCBRIDE A
PUGH W
COX J
CABANILLAS F
Citation: Ah. Sarris et al., THE NUMBER OF INVOLVED SITES (NIS) PREDICTS FAILURE-FREE SURVIVAL (FFS) FOR ADULTS WITH HODGKINS-DISEASE (HD) TREATED WITH ABVD OR EQUIVALENT REGIMENS, Blood, 90(10), 1997, pp. 3954-3954
Authors:
SARRIS AH
PRETI A
SMITH T
MESINA O
SANTIAGO M
HAGEMEISTER F
MCLAUGHLIN P
RODRIGUEZ MA
ROMAGUERA J
YOUNES A
RIGGS S
HA C
PUGH W
MCBRIDE A
COX J
CABANILLAS F
Citation: Ah. Sarris et al., A PREDICTIVE MODEL FOR FAILURE-FREE SURVIVAL (FFS) OF ADULTS WITH HODGKINS-DISEASE (HD) TREATED WITH AVBD OR EQUIVALENT REGIMENS, Blood, 90(10), 1997, pp. 1727-1727
Authors:
MERA JR
WHIMBEY E
ELTING L
PRETI A
LUNA MA
BRUNER JM
WILLIAMS T
BODEY GP
GOODRICH JM
Citation: Jr. Mera et al., CYTOMEGALOVIRUS PNEUMONIA IN ADULT NONTRANSPLANTATION PATIENTS WITH CANCER - REVIEW OF 20 CASES OCCURRING FROM 1964 THROUGH 1990, Clinical infectious diseases, 22(6), 1996, pp. 1046-1050
Citation: Mf. Aleo et al., ENZYMATIC-ACTIVITIES AFFECTING EXOGENOUS NICOTINAMIDE ADENINE-DINUCLEOTIDE IN HUMAN SKIN FIBROBLASTS, Journal of cellular physiology, 167(1), 1996, pp. 173-176
Authors:
SARRIS AH
STRAUS D
PRETI A
SMITH T
MYERS J
HESS M
PUGH W
CABANILLAS F
Citation: Ah. Sarris et al., A PROGNOSTIC MODEL FOR ADVANCED HODGKINS-DISEASE (HD) AT ANDERSON,M.D. (MDA) VALIDATED WITH AN INDEPENDENT SET OF PATIENTS TREATED AT MEMORIAL SLOAN-KETTERING (MSK), Blood, 88(10), 1996, pp. 893-893
Authors:
SARRIS AH
KLICHE KO
SMITH T
PRETI A
MESSINA O
HESS M
PUGH W
ANDREEFF M
CABANILLAS F
Citation: Ah. Sarris et al., ELEVATED SERUM IL-10 - AN ADVERSE PROGNOSTIC FACTOR FOR FAILURE-FREE SURVIVAL (FFS) IN ADULTS WITH ADVANCED HODGKINS-DISEASE (HD), Blood, 88(10), 1996, pp. 894-894
Authors:
FLAMMINIO G
MONTI E
GARGIULO F
VARINACCI C
MAGNI P
MARTINELLI F
CAIMI L
CARUSO A
PRETI A
TURANO A
Citation: G. Flamminio et al., PURIFICATION OF RECOMBINANT LAMB PROTEINS USING CONTINUOUS ELUTION ELECTROPHORESIS - A COMPARISON WITH IMMUNOAFFINITY CHROMATOGRAPHY, Biochemistry and molecular biology international, 36(6), 1995, pp. 1255-1261
Authors:
HAGEMEISTER FB
MCLAUGHLIN P
RODRIGUEZ MA
COX JD
HA CS
ROMAGUERA JE
SARRIS A
YOUNES A
BACHIER C
PRETI A
CABANILLAS F
Citation: Fb. Hagemeister et al., THE PRETREATMENT SERUM BETA-2-MICROGLOBULIN (BETA(2)M) IS THE MOST IMPORTANT FEATURE PREDICTING FREEDOM FROM PROGRESSION (FFP) IN CLINICALLY STAGED (CS) I-II HODGKINS-DISEASE (HD) TREATED WITH NOVP AND EXTENDED FIELD RADIOTHERAPY, Blood, 86(10), 1995, pp. 2108-2108
Authors:
PRETI A
HAGEMEISTER FB
MCLAUGHLIN P
SWAN F
RODRIGUEZ A
BESA P
COX JD
ALLEN PK
CABANILLAS F
Citation: A. Preti et al., HODGKINS-DISEASE WITH A MEDIASTINAL MASS GREATER-THAN 10 CM - RESULTSOF 4 DIFFERENT TREATMENT APPROACHES, Annals of oncology, 5, 1994, pp. 190000097-190000100
Authors:
PRETI A
KANTARJIAN HM
ESTEY E
HUH Y
KEATING M
PIERCE S
HIRSCHGINSBERG C
YEE G
STASS SA
Citation: A. Preti et al., CHARACTERISTICS AND OUTCOME OF PATIENTS WITH ACUTE LYMPHOCYTIC-LEUKEMIA AND MYELOPEROXIDASE-POSITIVE BLASTS BY ELECTRON-MICROSCOPY, Hematologic pathology, 8(4), 1994, pp. 155-167
Authors:
PRETI A
KANTARJIAN HM
ESTEY E
HUH Y
KEATING M
PIERCE S
HIRSCHGINSBERG C
YEE G
STASS SA
Citation: A. Preti et al., CHARACTERISTICS AND OUTCOME OF PATIENTS WITH ACUTE LYMPHOCYTIC-LEUKEMIA AND MYELOPEROXIDASE-POSITIVE BLASTS BY ELECTRON-MICROSCOPY, Hematologic pathology, 8(4), 1994, pp. 155-167
Citation: A. Preti et Hm. Kantarjian, MANAGEMENT OF ADULT ACUTE LYMPHOCYTIC-LEUKEMIA - PRESENT ISSUES AND KEY CHALLENGES, Journal of clinical oncology, 12(6), 1994, pp. 1312-1322
Authors:
PERINI G
ZARA M
CIPRIANI R
CARRARO C
PRETI A
GAVA F
COGHI P
PESERICO A
Citation: G. Perini et al., IMIPRAMINE IN ALOPECIA-AREATA - A DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY, Psychotherapy and psychosomatics, 61(3-4), 1994, pp. 195-198
Authors:
MARCHESINI S
DEMASI L
CESTONE P
PRETI A
AGMON V
DAGAN A
NAVON R
GATT S
Citation: S. Marchesini et al., SULFORHODAMINE GM(1)-GANGLIOSIDE - SYNTHESIS AND PHYSICOCHEMICAL PROPERTIES, Chemistry and physics of lipids, 72(2), 1994, pp. 143-152